发明名称 CHEMICAL COMPOUNDS
摘要 Improved systems for targetted enzyme prodrug therapy, especially antibody directed enzyme prodrug therapy (ADEPT), in which the enzyme used is a mutated form of a host enzyme in which the natural host enzyme, such as ribonuclease, recognises its natural substrate by an ion pair interaction and this interaction is reversed ("reversed polarity") in the design of mutated enzyme and complementary prodrug.
申请公布号 CA2205091(A1) 申请公布日期 1996.07.04
申请号 CA19952205091 申请日期 1995.12.21
申请人 ZENECA LIMITED 发明人 BOYLE, FRANCIS THOMAS;TARRAGONA-FIOL, ANTONIO;HENNEQUIN, LAURENT FRANCOIS ANDRE;SLATER, ANTHONY MICHAEL;HEATON, DAVID WILLIAM;DAVIES, DAVID HUW;RABIN, BRIAN ROBERT;HENNAM, JOHN FREDERICK;BLAKEY, DAVID CHARLES;MARSHAM, PETER ROBERT;EGGELTE, HENDRIKUS JOHANNES;TAYLORSON, CHRISTOPHER JOHN
分类号 C12N15/09;A61K31/70;A61K31/7042;A61K31/7052;A61K31/7064;A61K31/7068;A61K31/7072;A61K39/00;A61K39/395;A61K47/48;A61K48/00;A61P35/00;C07H19/10;C12N1/21;C12N9/48;C12P21/02;C12P21/08;C12R1/19;(IPC1-7):C12N15/62;C12N15/13;C12N9/22;C12N9/24;C12N15/55;C12N9/96 主分类号 C12N15/09
代理机构 代理人
主权项
地址